Phenolic-linked biochemical rationale for the anti-diabetic properties of Swertia chirayita (Roxb. ex Flem.) Karst.

Phytotherapy Research

Volumn 27, Issue 2, 2013, Pages 227-235

  Phoboo, Susanna ^a,b   Da Silva Pinto, Marcia ^a   Barbosa, Ana Cristina Lopes ^a   Sarkar, Dipayan ^a   Bhowmik, Prasanta C ^a   Jha, Pramod Kumar ^b   Shetty, Kalidas ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b TRIBHUVAN UNIVERSITY   (Nepal)

Author keywords

glucosidase inhibition; anti diabetic; antioxidant activity; mangiferin; Swertia chirayita

Indexed keywords

ALPHA GLUCOSIDASE; AMAROGENTIN; DIPEPTIDYL CARBOXYPEPTIDASE; MANGIFERIN; PLANT MEDICINAL PRODUCT; SWERCHIRIN; SWERTIA CHIRAYITA EXTRACT; SWERTIA EXTRACT; SWERTIAMARIN; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEALING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; IN VITRO STUDY; NEPAL; NONHUMAN; SWERTIA; SWERTIA CHIRAYITA;

ALPHA-GLUCOSIDASES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIOXIDANTS; BIPHENYL COMPOUNDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HYPOGLYCEMIC AGENTS; INHIBITORY CONCENTRATION 50; IRIDOIDS; NEPAL; PHENOLS; PICRATES; PLANT EXTRACTS; SWERTIA; XANTHONES;

SWERTIA;

EID: 84873412230     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4714     Document Type: Article

References (37)

1. Andreu GP, Delgado R, Velho JA, Curti C, Vercesi AE,. 2005. Iron complexing activity of mangiferin, a naturally occurring lucosylxantone, inhibits mitochondrial lipid peroxidation induced by Fe (2+) citrate. Eur J Pharmacol 513: 47-55.
2. Balasundari P, Singh S, Kavimani S,. 2005. Free radical scavenging of xanthones from Swertia chirata Buchham and tumor cell growth inhibition. Main Group Chem 4: 177-185.
3. Baron AD,. 1998. Post prandial hypoglycemia and α-glucosidase inhibitors. Diabetes Res Clin Pract 40: S51-S55.
4. Baynes JW, Thorpe SR,. 1999. Perspectives in diabetes. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 48: 1-9.
5. Braga FC, Serra CP, Junior NSV, Oliveira AB, Cortes SF, Lombardi JA,. 2007. Angiotensin-converting enzyme inhibition by Brazilian plants. Fitoterapia 78: 353-358.
6. Dar A, Faizi S, Naqvi S, et al,. 2005. Analgesic and antioxidant activity of mangiferin and its derivatives: the structure activity relationship. Biol Pharm Bull 28: 596-600.
7. Dembinska-Kiec A, Mykkanen O, Kiec-Wilk B, Mykkanen H,. 2008. Antioxidant phytochemicals against type 2 diabetes. Br J Nutr 99 (E-Suppl.1): ES 109-ES 117.
8. Garrido G, Gonzalez D, Lemus Y, et al,. 2004. In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (Vimang). Pharmacol Res 50: 143-149.
9. Han X, Shen T, Lou H,. 2007. Dietary Polyphenols and Their Biological Significance. Int J Mol Science 8: 950-988.
10. Hanson RL, Imperatore G, Bennett PH, Knowler WC,. 2002. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51: 3121-3127.
11. Jeyaramraja PR, Pius PK, Jayakumar JD,. 2003. Soil moisture stress-induced alterations in bioconstituents determining tea quality. J Sci Food Agric 83: 1187-1191.
12. Johnston CI,. 1994. Tissue angiotensin converting enzyme in tissue and vascular hypertrophy, repair and remodeling (clinical conference). Hypertension 23: 258-268.
13. Kumarasay Y, Nahar L, Cox PJ, Jaspars M, Sarker SD,. 2003. Bioactivity of secoiridoid glycosides from Centaurium erythraea. Phytomedicine 10: 344-347.
14. Kusar A, Zupancic A, Sentjurc M, Baricevic D,. 2006. Free radical scavenging activities of yellow gentian (Gentiana lutea L.) measured by electron spin resonance. Hum Exp Toxicol 25: 599-604.
15. Kwon YI, Vattem DV, Shetty K,. 2006. Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension. Asia Pac J Clin Nutr 15: 107-118.
16. Leiro JM, Amvarez E, Arranz JA, Siso IG, Orallo F,. 2003. In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthetase, tumour necrosis factor-alpha and transforming growth factor-beta genes. Biochem Pharmacol 65: 1361-1371.
17. Leslie ER, Chungath JI,. 1987. Studies on Swertia chirata. Indian Drugs 25: 143.
18. MCCue P, Kwon YI, Shetty K,. 2005. Anti-amylase, anti-glucosidase and anti-angiotensin I-converting enzyme potential of selected foods. J Food Sci Biotechnol 29: 278-294.
19. Muruganandan S, Srinivas K, Gupta S, Gupta PK, Lal J,. 2005. Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats. J Ethnopharmacol 97: 497-501.
20. Nair PS, Devi CSS,. 2006. Efficacy of mangiferin on serum and heart tissue lipids in rat subjected to isoproterenol induced cardiotoxicity. Toxicology 228: 135-139.
21. Ohsawa M, Shakya PR, Numata M,. 1986. Distribution and succession of West Himalayan forest types in the Eastern part of the Nepal Himalaya. Mountain Res Dev 6: 143-157.
22. Pickup JC,. 2004. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27: 813-823.
23. Saha P, Mandal S, Das A, Das PC, Das S,. 2004. Evaluation of anti-carcinogenic activity of Swertia chirata Buch. Ham, an Indian medicinal plant on DMBA-induced mouse skin carcinogenesis model. Phytother Res 18: 373-378.
24. Sapkota PP,. 2008. Ethno-ecological observation of Magar of Bikini, Baglung, Western Nepal. Dhaulagiri J Soc Anthropol 2: 227-252.
25. Saxena AM, Mukherjee SK,. 1992. Mechanism of blood lowering action of Swertia chirayita: effect of impure swerchrin (SWI) on insulin release from isolated beta cells of the pancreas. J Micro Biotechnol 7: 27-29.
26. Saxena AM, Bajpai BM, Murthy PSR, Mukherjee S,. 1993. Mechanism of blood sugar lowering by a swerchirin-containing hexane fraction (SWI) of Swertia chirayita. Indian J Exp Biol 31: 178-181.
27. Sekar BC, Mukherjee B, Chakravarti RB, Mukherjee SK,. 1987. Effect of different fractions of Swertia chirayita on the blood sugar level of albino rats. J Ethnopharmacol 21: 175-181.
28. Sellamuthu PS, Muniappan BP, Perumal SM, Kandasamy M,. 2009. Antihyperglycemic effect of mangiferin in streptozotocin induced diabetic rats. J Health Sci 55: 206-214.
29. Shetty K, Curtis OF, Levin RE, Wikowsky R, Ang W,. 1995. Prevention of verification associated with in vitro shoot culture of oregano (Origanum vulgare) by Pseudomonas spp. J Plant Physiol 147: 447-451.
30. Sicree R, Shaw J, Zimmet P,. 2006. Prevalence and projections. In Diabetes Atlas. World Diabetes Foundation (3rd edn), Gan D, (ed.) International Diabetes Federation: Brussels, Belgium; 16-104.
31. Suryawanshi S, Mehrotra N, Asthana RK, Gupta RC,. 2006. Liquid chromatography/tandem mass spectrometric study and analysis of Swertia chirata, a potent antidiabetic. Rapid Comm Mass Spectrom 20: 3761-3768.
32. Verma H, Patil PR, Kolhapure RM, Gopalkrishna V,. 2008. Antiviral activity of the Indian medicinal plant extract, Swertia chirata against herpes simplex virus: a study by in vitro and molecular approach. Indian J Med Microbiol 26: 322-326.
33. Waqar MA, Shaukat S,. 2006. Diabetes mellitus-the pertinent exploration of herbal treatments. J Chem Soc Pakistan 28: 391-396.
34. Worthington V,. (Ed.) 1993. Maltase-a-glucosidase. In Worthington Enzyme Manual, Worthington Biochemical Corp: Freehold, NJ; 261.
35. Yang Y, Marczak ED, Yokoo M, Usui H, Yoshokawa M,. 2003. Isolation and antihypertensive effect of Angiotensin 1-converting enzyme (ACE) inhibitory peptides from spinach Rubisco. J Agr Food Chem 51: 4897-4902.
36. Yoshikawa M, Nishida N, Shimoda H, Takada M, Kawahara Y, Matsuda H,. 2001. Polyphenol constituents from Salacia species: quantitative analysis of mangiferin with α-glucosidase and aldose reductase inhibitory activities. Yakugaku Zasshi 121: 371-378.
37. Zimmet P, Alberti KGMM, Shaw J,. 2001. Global and societal implication of the diabetes epidemic. Nature 414: 782-787.